F
Fate Therapeutics
Stem cell and developmental biology research company using biological mechanisms to develop stem cell therapeutics
At a glance
- Status
- Listed
- Founded
- 2007
- Headquarters
- San Diego, United States
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Outcome tier
- Unicorn$1–10B valuation tier
Knowledge graph
Open roles
Fate Therapeutics in the San Diego ecosystem
The Fate Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Venrock
Polaris Partners- OPOVP Venture Partners
ARCH Venture Partners
Series B and later7 investors entered at this stage
- CBChildren’s Hospital Boston
- HUHarvard University
- SIScripps Translational Science Institute
- MHMassachusetts General Hospital
- AVAstellas Venture
- UWUniversity of Washington
- SUStanford University
Source: Dealroom Talent Intelligence.
Alumni founders
Former Fate Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
SRScholar RockEst. 2012
Leonard ZonUnited States
VTVivace TherapeuticsEst. 2014
Sheng DingUnited States
Peter FlynnUnited States
SPSyros PharmaceuticalsEst. 2012
Alex RivesUnited States
David ScaddenUnited StatesGlobal footprint
team presence
across markets
Patents
48 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Fate Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Fate Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


